Molecular hydrogen inhibits neuroinflammation and ameliorates depressive-like behaviors and short-term cognitive impairment in senescence-accelerated mouse prone 8 mice.
Abstract
Neuroinflammation, a low-grade chronic inflammation of the central nervous system, is linked to age-related neuropsychiatric disorders such as senile depression and Alzheimer's disease. Recent studies have explored controlling neuroinflammation as a novel treatment strategy. Molecular hydrogen shows anti-inflammatory effects. However, its impacts on neuroinflammation and age-related neuropsychiatric disorders remain unelucidated. We investigated molecular hydrogen's effects on microglial activation, neuroinflammation, depressive-like behavior, and short-term cognitive decline in senescence-accelerated mouse-prone 8 (SAMP8) mice.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper investigates the effects of molecular hydrogen on neuroinflammation and associated depressive-like behaviors in a mouse model of accelerated aging. While it addresses neuroinflammation, which is linked to age-related disorders, the focus is primarily on symptom management rather than addressing the root causes of aging or lifespan extension. The findings may contribute to understanding neuroinflammation in aging but do not significantly advance the field of longevity research. Thus, it is rated as a solid contribution with limited impact.
Author of this paper? Send a correction.